1. Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells. (3rd July 2019) Authors: Ochoa, Maria C.; Perez-Ruiz, Elisabeth; Minute, Luna; Oñate, Carmen; Perez, Guiomar; Rodriguez, Inmaculada; Zabaleta, Aintzane; Alignani, Diego; Fernandez-Sendin, Myriam; Lopez, Ascension; Muntasell, Aura; Sanmamed, Miguel F.; Paiva, Bruno; Lopez-Botet, Miguel; Berraondo, Pedro; Melero, Ignacio Journal: Oncoimmunology Issue: Volume 8:Number 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗